Spring 2023 MIT Webconference
June 7 - 8
The Longwood Healthcare Leaders Spring MIT Webconference is co-hosted by Nobelist Phil Sharp and centered on MIT’s Koch Institute via ZOOM with top biopharma CEOs, heads of R&D, life science investors, and leading researchers in an off-the-record setting.
Registered participants are invited to join a cocktail reception in Boston at the close of the meeting, June 8, 5 –7 pm.
Featured Speakers
Longwood Healthcare Leaders Spring Webconference
June 7-8, 2023
Agenda
.jpg)
7:30 am ET
LONGWOOD FUND INTRODUCTION
Christoph Westphal, General Partner, Longwood Fund
8:00 am ET
NEWCO: SHAPING THE NARRATIVE
8:30 am ET
BIG BIOPHARMA R&D
Glenn Gormley, Head, R&D; Executive Chair & President, Daiichi Sankyo
Sek Kathiresan, CEO, Verve Therapeutics
9:00 am ET
REGULATORY KEYNOTE
Peter Marks, Director, Center for Biologics Evaluation and Research, FDA
9:20 am ET
SPOTLIGHT ON MIT INNOVATION
Angie Belcher, Head of the Department of Biological Engineering, MIT
Sangeeta Bhatia, Director, Marble Center for Cancer Nanomedicine, MIT
Paula Hammond, Institute Professor; Department Head, Chemical Engineering, MIT
Moderator: Jane Wilkinson, Executive Director, Koch Institute at MIT
9:50 am ET
INNOVATION IN THE ERA OF IRA
10:20 am ET
ACCELERATING THE PATH TO PATIENT CARE
Arpa Garay, Chief Commercial Officer, Moderna
Richard Paulson, CEO, Karyopharm
David Weinreich, EVP, Head, Global Clinical Development; Co-Head, Global Development, Regeneron
10:50 am ET
FIRESIDE CHAT
11:10 am ET
EXPLOSION OF MODALITIES
John Lepore, SVP, Head, Research, GlaxoSmithKline
Jim List, Global TA Head, CV, Metabolism, Retina & Pulmonary Hypertension, Janssen R&D
Anabella Villalobos, SVP, Biotherapeutics & Medicinal Sciences, Biogen
11:40 am ET
TIMING THE IPO
12:10 pm ET
NOVEL APPROACHES TO DRUG DISCOVERY
Alise Reicin, CEO, Tectonic Therapeutics
Kathy Seidl, Head, Oncology Drug Discovery, Takeda
12:40 pm ET
CULTIVATING AN ECOSYSTEM OF PARTNERS
John Flavin, Chair, Pyxis Oncology
John Glasspool, CEO, Anthos Therapeutics
Heather Schwoebel, COO & CBO, Alloy Therapeutics
Ramona Sequeira, President, Global Portfolio, Takeda
1:10 pm ET
MOVING FROM TREATMENT TO CURE
Kara Carter, EIR, Evotec
1:30 pm ET
FIRESIDE CHAT
1:50 pm ET
TRANSFERRING TECHNOLOGY FROM ACADEMIA
Phil Johnson, CEO, Interius
2:20 pm ET
EARLY PREPARATION FOR PARTNERING
Stu Mackey, Global Head, BD, Daiichi Sankyo
Amanda Wagner, CEO, Immunitas
2:50 pm ET
PREPARING FOR THE FUTURE OF R&D
Fabrice Chouraqui, CEO, Cellarity
Lloyd Minor, Dean, Stanford Medicine
Zhen Su, CEO, Marengo Therapeutics
3:20 pm ET
FIRESIDE CHAT
3:40 pm ET
ACCELERATING DRUG DEVELOPMENT
Anirvan Ghosh, CEO, Unity Biotechnology
4:10 pm ET
CONVENING A STRONG SYNDICATE
Ansbert Gadicke, Managing Director, MPM Capital
4:40 pm ET
LONGWOOD FUND UPDATE
.png)
Wednesday Agenda
.jpg)
Thursday Agenda
7:30 am ET
LONGWOOD FUND INTRODUCTION
David Steinberg, General Partner, Longwood Fund
8:00 am ET
PORTFOLIO COMPANY PRESENTATION
8:20 am ET
BIG BIOPHARMA PIPELINE SOURCING
David Loew, CEO, Ipsen
John Reed, EVP, Global Head, R&D, Sanofi
8:50 am ET
CROSS-BORDER COLLABORATION
Rachna Khosla, SVP, BD, Amgen
Neil Warma, CEO, Genexine
9:20 am ET
DATA SCIENCE EVOLUTION & ENABLEMENT
9:50 am ET
FIRESIDE CHAT
Phil Sharp, Institute Professor, MIT; Nobel Laureate & Co-Founder, Alnylam/Biogen
10:10 am ET
ADVANCES IN CLINICAL TRIALS
Maria Maccecchini, CEO, Annovis Bio
10:40 am ET
MAXIMIZING PLATFORM POTENTIAL
Guillaume Pfefer, CEO, Senda Biosciences
11:10 am ET
ADVANCES IN NEUROSCIENCE
Saul Kato, CEO, Herophilus
11:40 am ET
FIRESIDE CHAT
12:00 pm ET
LIFE SCIENCE MARKET OUTLOOK
Rahul Kakkar, Entrepreneur-Partner, Polaris
12:30 pm ET
R&D COLLABORATION
Bill Mezzanotte, Head, R&D & CMO, CSL
1:00 pm ET
ALIGNING PRIORITIES WITH THE BOARD
Al Gianchetti, CEO, XyloCor Therapeutics
John McCabe, CFO & COO, DEM Biopharma
1:30 pm ET
IMPLEMENTING A FOUNDATIONAL PARTNERING STRATEGY
Krishnan Viswanadhan, COO, Be Bio
2:00 pm ET
FIRESIDE CHAT: 340B DRUG PRICING & REFORMS
Alexander Hardy, CEO, Genentech
2:20 pm ET
OPTIMIZING THE PIPELINE
José Trevejo, CMO, Tarsus
2:50 pm ET
SOURCING AND IDENTIFYING NOVEL TECHNOLOGY
Michal Preminger, Head, Innovation, Johnson & Johnson, East North America
3:20 pm ET
FIRESIDE CHAT
Andy Plump, President, R&D, Takeda
Rupert Vessey, President, Research & Early Development, Bristol Myers Squibb
3:40 pm ET
NAVIGATING REGULATORY CHALLENGES
Rachelle Jacques, CEO, Akari
Eliezer Katz, CMO, eGenesis
4:10 pm ET
FINANCING INNOVATION
Karin Kleinhans, Partner, MRL Ventures Fund
4:40 pm ET
LONGWOOD FUND UPDATE
.png)
.png)
Thursday, June 8, 2023
5:00pm - 7:00pm
Registered participants are invited to join a cocktail reception at MIT’s Koch Institute at the close of the meeting.
Cocktail Reception
These meetings are focused on accelerating the translation of discoveries into medicines to help patients; donations enabled by these meetings benefit The Boston Foundation, BSO, Harvard Medical School, MIT, Life Science Cares, and other charities.
.jpg)
.png)
.jpg)
